These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36938304)

  • 1. FDA preemption of conflicting state drug regulation and the looming battle over abortion medications.
    Grossi P; O'Connor D
    J Law Biosci; 2023; 10(1):lsad005. PubMed ID: 36938304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buckman extended: federal preemption of state fraud-on-the-FDA statutes.
    Gaddis CA
    Food Drug Law J; 2014; 69(1):113-36, iii. PubMed ID: 24772688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mifepristone, preemption, and public health federalism.
    Zettler PJ; Beckmeyer A; Brown BL; Sarpatwari A
    J Law Biosci; 2022; 9(2):lsac037. PubMed ID: 36568649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of Wyeth v. Levine on FDA regulation of prescription drugs.
    Ausness RC
    Food Drug Law J; 2010; 65(2):247-83, i-ii. PubMed ID: 24475542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preemption of the "fraud on the FDA" exception to Michigan's tort immunity statute for drug manufacturers: reconsidering Garcia and Desiano after Levine.
    Murdey J
    Food Drug Law J; 2011; 66(1):85-104, ii-iii. PubMed ID: 24505848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief of over 300 reproductive health researchers as Amici Curiae in FDA v. Alliance for Hippocratic Medicine.
    Barrow A; Cohen C; Serpico J; Goodman M; Grossman D; Raifman S; Upadhyay U
    Perspect Sex Reprod Health; 2024 Jul; ():. PubMed ID: 39074980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mifepristone REMS: A needless and unlawful barrier to care✰.
    Kaye J; Reeves R; Chaiten L
    Contraception; 2021 Jul; 104(1):12-15. PubMed ID: 33930383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The demise of drug design litigation: death by federal preemption.
    Twerski AD
    Am Univ Law Rev; 2018; 68(1):281-304. PubMed ID: 30457769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remote Reproductive Rights.
    Rebouché R
    Am J Law Med; 2022 Jul; 48(2-3):244-255. PubMed ID: 36715252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should preemption apply in a pharmaceutical context? An analysis of the preemption debate and what regulatory compliance statutes contribute to the discussion.
    Surprenant JA
    Fordham Law Rev; 2008 Oct; 77(1):327-63. PubMed ID: 18982554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Your business in court and at federal agencies: 2010 - 2011.
    Reiss JB; Crowder D; Simons B; Pleskov I; Davis T; Nugent P
    Food Drug Law J; 2012; 67(2):243-92, iii. PubMed ID: 24620420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Mifepristone Litigation: Untangling the Implications of the Fifth Circuit's Decision for Abortion Access and the U.S. Food and Drug Administration.
    Zettler PJ; Grossman LA; Adashi EY; Cohen IG
    Ann Intern Med; 2023 Dec; 176(12):1666-1669. PubMed ID: 37931255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tort reform by regulation: FDA prescription drug labeling rules and preemption of state tort claims.
    Moreland MP
    J Health Life Sci Law; 2007; 1(1):39, 41-62. PubMed ID: 18610730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benten v. Kessler: the RU 486 import case.
    Pine RN
    Law Med Health Care; 1992; 20(3):238-42. PubMed ID: 1434768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life after Riegel: a fresh look at medical device preemption one year after Riegel v. Medtronic, Inc.
    Wartman GJ
    Food Drug Law J; 2009; 64(2):291-311. PubMed ID: 19999286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA preemption of drug and device labeling: who should decide what goes on a drug label?
    Valoir T; Ghosh S
    Health Matrix Clevel; 2011; 21(2):555-98. PubMed ID: 22145525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics✰,✰✰.
    Razon N; Wulf S; Perez C; McNeil S; Maldonado L; Fields AB; Carvajal D; Logan R; Dehlendorf C
    Contraception; 2022 May; 109():19-24. PubMed ID: 35131289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.